Canada markets closed

Celyad Oncology SA (CYAD.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
0.3045+0.0005 (+0.16%)
At close: 05:29PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-30,619
-40,935
-26,512
-17,204
-28,632
Depreciation & amortization
-
1,440
1,520
1,832
1,788
Stock based compensation
-
1,624
2,172
2,782
2,775
Change in working capital
-
-4,015
1,405
-2,874
-610
Accounts Payable
-
-4,321
2,964
-1,726
1,162
Other working capital
-
-28,133
-27,036
-27,984
-28,824
Other non-cash items
-
-18,342
-4,697
-13,250
-3,608
Net cash provided by operating activites
-
-28,010
-26,643
-27,665
-28,202
Cash flows from investing activities
Investments in property, plant and equipment
-
-123
-393
-319
-622
Acquisitions, net
-
-
-
-
0
Purchases of investments
-
-
-
0
0
Sales/Maturities of investments
-
1,090
0
0
9,379
Net cash used for investing activites
-
7,202
-126
157
8,987
Cash flows from financing activities
Debt repayment
-
-896
-1,136
-1,447
-1,487
Common stock issued
-
-
36,568
0
16,448
Common stock repurchased
-
-124
-
-
-
Other financing activites
-
4,261
4,089
6,843
3,315
Net cash used privided by (used for) financing activities
-
3,241
39,521
5,396
18,276
Net change in cash
-
-17,567
12,752
-22,112
-940
Cash at beginning of period
-
30,018
17,234
39,338
40,542
Cash at end of period
-
12,445
30,018
17,234
39,338
Free Cash Flow
Operating Cash Flow
-
-28,010
-26,643
-27,665
-28,202
Capital Expenditure
-
-123
-393
-319
-622
Free Cash Flow
-
-28,133
-27,036
-27,984
-28,824